BVS
NASDAQ
$11.58
Bioventus Inc - Class A (BVS)
Bioventus Inc., a medical device company, focuses on developing and commercializing clinical treatments that involve and enhance the body's natural healing process in the United States and internationally. The company is headquartered in Durham, North Carolina.
Sector:
Healthcare
Industry:
Medical Devices
Strong Buy
Target: $14.80 (+27.81%)
Market Cap
$806M
Revenue 5Y CAGR
+67.50%
FCF 5Y CAGR
+26.63%
Forward P/E
15.38
Price Chart
Valuation
Market Cap$806M
P/E72.28
Forward P/E15.38
PEG1.47
P/S1.41
P/B4.15
Profitability
Total Revenue (TTM)$576M
Gross Profit (TTM)$396M
EBITDA$104M
Profit Margin2.4%
Operating Margin6.4%
EPS$0.17
Financial Health
Debt-to-Equity144%
Free Cash Flow Yield12.49%
Growth & Risk
Revenue 5Y CAGR+67.50%
FCF 5Y CAGR+26.63%
Beta (5Y)0.92
Sharpe Ratio1.29